Controlled Substances and Substance Abuse: Best Practices for the Healthcare Professional
The abuse of controlled substances, including stimulants, opioids, sedatives, and tranquilizers, presents a significant public health challenge nationwide. This educational program delves deeply into the array of medications classified as controlled substances by federal regulations. Additionally, it equips healthcare professionals with vital insights into the hazards linked to prescribing such substances, along with strategies for their safe and efficient use, prescription, and the detection and prevention of substance misuse.
Target Audience
Dental Therapist, Podiatric Temporary Residency, Podiatric Medical Radiological Technicians, Certified Respiratory Therapist, Advanced Practice Nurse Prescribers, Certified Nurse Midwife, Licensed Midwife, Expanded Function Dental Assistant, Advanced Dental Assistant, Registered Respiratory Therapist, Dental Hygienist, Expanded Function Dental Auxillary, Registered Nurse Practitioner, Licensed Psychiatric Technician Nurse, Certified Nurse Practitioner, APRN - Certified Nurse Midwife, Advanced Practice Nurses, Licensed Practical Nurse, Forensic Nurse-CSA, Certified Registered Nurse Anesthetist, Psychiatric Nurse, Clinical Nurse Specialist, Dentist, Registered Nurse, Podiatric Physician, Long-Term Care Facility Administrators, Licensed Vocational Nurse, Public Health Nurse, Licensed Nursing Assistant, Physician Assistant, Advanced Practice Registered Nurse, Respiratory Therapist, Nursing Home Administrator, Community Dental Health Coordinator, Dental Technician, Respiratory Care Practitioner Critical Care, Respiratory Care Practitioner, Dental Lab, Certified Nursing Assistant, Respiratory Care Practitioner Non-Critical Care, Denturist, Pharmacy Technician, Registered Dental Assistant, General Dentist, Dental Assistant Radiographer, Dental Assistant
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Describe the scope of the drug abuse epidemic in the United States.
- Describe the differences between drug misuse, drug abuse, and addiction.
- Identify how controlled substances are classified according to schedules and provide examples of drugs on each schedule.
- Identify commonly misused and diverted drugs as well as sources for diversion.
- Describe behaviors that could indicate drug misuse or diversion on the part of a patient or doctor.
- Identify risk factors for drug misuse or diversion.
- Identify best practices that prescribers can implement to prevent drug misuse or diversion.
Course Preview
Introduction
- The Scope of the Drug Abuse Epidemic
- Drug Misuse, Abuse, and Addiction Defined
Overview of Schedules of Controlled Substances
- Commonly Diverted and Abused Drugs
- Common Drug Diversion Techniques
- Risk Factors for Drug Diversion and Abuse
Chronic Pain and Controlled Substances
Mental Illness and Controlled Substances
Attention Deficit Hyperactivity Disorder and Controlled Substances
Prescribing Emergency Opioid Antagonists
- What Is Naloxone?
- Increasing Naloxone Awareness and Use
- Engaging Patients in a Conversation About Naloxone
- Reducing Stigma Surrounding Naloxone
Preventing Prescription Drug Diversion and Abuse
Nonpharmacological Therapies
- Chronic Low Back Back
- Chronic Neck Pain
- Osteoarthritis Pain
- Fibromyalgia
- Chronic Tension Headache
- Differential Efficacy
- Harms
Nonopioid Medications for Pain
- Interventions
Responsible Prescription of Controlled Substances
Prescribing Guidelines for Controlled Substances
- CDC Prescribing Guidelines
- Determining Whether or Not to Initiate Opioids for Pain
- Selecting Opioids and Determining Opioid Dosages
- Deciding Duration of Initial Opioid Prescription and Conducting Follow-Up
- Assessing Risk and Addressing Potential Harms of Opioid Use
- Management of Opioid Misuse That Does Not Meet Criteria for Opioid Use Disorder
- Pain Management for Patients with Opioid Use Disorder
Conclusion
Additional Information
John Villa MD, FACEP, FAAFP
John Francis Villa, MD, FACEP, FAAFP is an Emergency Medicine Specialist in Florida with more than 25 years in emergency medicine and family medicine.
Nursing
AchieveCE is an approved provider of nursing continuing professional development by the Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. GNA Approved Provider Number is 4003268.
- Arkansas State Board of Nursing
- California Board of Nursing
- District of Columbia Board of Nursing
- District of Columbia Board of Nursing Assistive Personnel
- Florida Board of Nursing
- Florida Board of Nursing - Certified Nursing Assistants
- Florida Board of Nursing Home Administrators
- Georgia Board of Nursing
- Kansas State Board of Nursing
- Kentucky Board of Nursing
- Michigan Board of Nursing
- Mississippi Board of Nursing
- New Mexico Board of Nursing
- New Mexico Certified Nurse Midwives and Licensed Midwives
- North Dakota Board of Nursing
- South Carolina Board of Nursing
- West Virginia Board of Registered Nurses
- Wyoming Board of Nursing
Nursing Home
AchieveCE is an approved provider (Provider #50-20641) of continuing education for long term care facility professionals.
Georgia State Board of Long-Term Care Facility Administrators
Midwifery
AchieveCE is an approved provider (Provider #50-20641) of continuing education for midwifery professionals.
- Florida Council of Licensed Midwifery
- New Mexico Certified Nurse Midwives and Licensed Midwives
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Continuing Education Company, Inc. and AchieveCE. Continuing Education Company, Inc. is accredited by the ACCME to provide continuing medical education for physicians.
Continuing Education Company, Inc. designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release Date: 3/6/2024
Expiration Date: 3/6/2025 (Date after which this enduring material is no longer certified for credit.)
Medium: Enduring Material
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 3.00 Contact hours